TrialBlood advances2020

Pacritinib demonstrates spleen volume reduction in patients with myelofibrosis independent of JAK2V617F allele burden.

Douglas Tremblay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.